Healthcare

North America Latanoprost Market by Manufacturers, Countries, Type and Application, Forecast to 2022

  • GLO2153847
  • 119 Pages
  • October 2017
  • Healthcare
Download Sample    Get Discount   
 
"Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness."

Scope of the Report:

This report focuses on the Latanoprost in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

Pfizer

Mylan

Novartis

Apotex

Teva

Taj Pharma

CR Zizhu

Market Segment by Countries, covering

United States

Canada

Mexico

Market Segment by Type, covers

Brand Drug

Generic Drug

Market Segment by Applications, can be divided into

Open-angle Glaucoma

Close-angle Glaucoma

There are 15 Chapters to deeply display the North America Latanoprost market.

Chapter 1, to describe Latanoprost Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Latanoprost, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Latanoprost, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Latanoprost market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Latanoprost Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents

1 Market Overview

1.1 Latanoprost Introduction

1.2 Market Analysis by Type

1.2.1 Brand Drug

1.2.2 Generic Drug

1.3 Market Analysis by Applications

1.3.1 Open-angle Glaucoma

1.3.2 Close-angle Glaucoma

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Profile

2.1.2 Latanoprost Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Pfizer News

2.2 Mylan

2.2.1 Profile

2.2.2 Latanoprost Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Mylan News

2.3 Novartis

2.3.1 Profile

2.3.2 Latanoprost Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Novartis News

2.4 Apotex

2.4.1 Profile

2.4.2 Latanoprost Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Apotex News

2.5 Teva

2.5.1 Profile

2.5.2 Latanoprost Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Teva News

2.6 Taj Pharma

2.6.1 Profile

2.6.2 Latanoprost Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Taj Pharma News

2.7 CR Zizhu

2.7.1 Profile

2.7.2 Latanoprost Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 CR Zizhu News

3 North America Latanoprost Market Competition, by Manufacturer

3.1 North America Latanoprost Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Latanoprost Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Latanoprost Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Latanoprost Manufacturer Market Share

3.4.2 Top 5 Latanoprost Manufacturer Market Share

3.5 Market Competition Trend

4 North America Latanoprost Market Analysis by Countries

4.1 North America Latanoprost Sales Market Share by Countries

4.2 North America Latanoprost Sales by Countries (2012-2017)

4.3 North America Latanoprost Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Latanoprost by Type

5.1 North America Latanoprost Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Latanoprost Sales and Market Share by Type (2012-2017)

5.1.2 North America Latanoprost Revenue and Market Share by Type (2012-2017)

5.2 Brand Drug Sales Growth and Price

5.2.1 North America Brand Drug Sales Growth (2012-2017)

5.2.2 North America Brand Drug Price (2012-2017)

5.3 Generic Drug Sales Growth and Price

5.3.1 North America Generic Drug Sales Growth (2012-2017)

5.3.2 North America Generic Drug Price (2012-2017)

6 North America Market Segmentation Latanoprost by Application

6.1 North America Latanoprost Sales Market Share by Application (2012-2017)

6.2 Open-angle Glaucoma Sales Growth (2012-2017)

6.3 Close-angle Glaucoma Sales Growth (2012-2017)

7 United States Latanoprost Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Latanoprost Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Latanoprost Sales and Market Share by Type

7.3 United States Latanoprost Sales by Application (2012-2017)

7.4 United States Latanoprost Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Latanoprost Sales and Market Share by Manufacturer

7.4.2 United States Latanoprost Revenue and Market Share by Manufacturer

7.5 United States Latanoprost Export and Import (2012-2017)

8 Canada Latanoprost Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Latanoprost Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Latanoprost Sales and Market Share by Type

8.3 Canada Latanoprost Sales by Application (2012-2017)

8.4 Canada Latanoprost Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Latanoprost Sales and Market Share by Manufacturer

8.4.2 Canada Latanoprost Revenue and Market Share by Manufacturer

8.5 Canada Latanoprost Export and Import (2012-2017)

9 Mexico Latanoprost Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Latanoprost Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Latanoprost Sales and Market Share by Type

9.3 Mexico Latanoprost Sales by Application (2012-2017)

9.4 Mexico Latanoprost Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Latanoprost Sales and Market Share by Manufacturer

9.4.2 Mexico Latanoprost Revenue and Market Share by Manufacturer

9.5 Mexico Latanoprost Export and Import (2012-2017)

10 Latanoprost Market Forecast (2017-2022)

10.1 North America Latanoprost Sales, Revenue and Growth Rate (2017-2022)

10.2 Latanoprost Market Forecast by Countries (2017-2022)

10.2.1 United States Latanoprost Forecast (2017-2022)

10.2.2 Canada Latanoprost Forecast (2017-2022)

10.2.3 Mexico Latanoprost Forecast (2017-2022)

10.3 Latanoprost Market Forecast by Type (2017-2022)

10.4 Latanoprost Market Forecast by Application (2017-2022)

11 Latanoprost Manufacturing Cost Analysis

11.1 Latanoprost Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Latanoprost

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Latanoprost Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Latanoprost Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data Source

List of Tables and Figures

Figure Latanoprost Picture

Table Product Specifications of Latanoprost

Figure North America Sales Market Share of Latanoprost by Types in 2016

Table Types of Latanoprost

Figure Brand Drug Picture

Table Major Manufacturers of Brand Drug

Figure Generic Drug Picture

Table Major Manufacturers of Generic Drug

Table North America Latanoprost Sales Market Share by Applications in 2016

Table Applications of Latanoprost

Figure Open-angle Glaucoma Picture

Figure Close-angle Glaucoma Picture

Figure United States Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Latanoprost Type and Applications

Table Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Latanoprost Type and Applications

Table Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Latanoprost Type and Applications

Table Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Apotex Basic Information, Manufacturing Base and Competitors

Table Apotex Latanoprost Type and Applications

Table Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Latanoprost Type and Applications

Table Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Taj Pharma Basic Information, Manufacturing Base and Competitors

Table Taj Pharma Latanoprost Type and Applications

Table Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table CR Zizhu Basic Information, Manufacturing Base and Competitors

Table CR Zizhu Latanoprost Type and Applications

Table CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Latanoprost Sales by Manufacturer (2016-2017)

Figure North America Latanoprost Sales Market Share by Manufacturer in 2016

Figure North America Latanoprost Sales Market Share by Manufacturer in 2017

Table North America Latanoprost Revenue by Manufacturer (2016-2017)

Figure North America Latanoprost Revenue Market Share by Manufacturer in 2016

Figure North America Latanoprost Revenue Market Share by Manufacturer in 2017

Table North America Latanoprost Price by Manufacturers (2016-2017)

Figure Top 3 Latanoprost Manufacturer Market Share in 2016

Figure Top 3 Latanoprost Manufacturer Market Share in 2017

Figure Top 5 Latanoprost Manufacturer Market Share in 2016

Figure Top 5 Latanoprost Manufacturer Market Share in 2017

Figure North America Latanoprost Sales and Growth (2012-2017)

Table North America Latanoprost Sales by Countries (2012-2017)

Table North America Latanoprost Sales Market Share by Countries (2012-2017)

Figure North America 2012 Latanoprost Sales Market Share by Countries

Figure North America 2016 Latanoprost Sales Market Share by Countries

Figure North America Latanoprost Revenue and Growth (2012-2017)

Table North America Latanoprost Revenue by Countries (2012-2017)

Table North America Latanoprost Revenue Market Share by Countries (2012-2017)

Table North America 2012 Latanoprost Revenue Market Share by Countries

Table North America 2016 Latanoprost Revenue Market Share by Countries

Table North America Latanoprost Sales by Type (2012-2017)

Table North America Latanoprost Sales Share by Type (2012-2017)

Table North America Latanoprost Revenue by Type (2012-2017)

Table North America Latanoprost Revenue Share by Type (2012-2017)

Figure North America Brand Drug Sales Growth (2012-2017)

Figure North America Brand Drug Price (2012-2017)

Figure North America Generic Drug Sales Growth (2012-2017)

Figure North America Generic Drug Price (2012-2017)

Table North America Latanoprost Sales by Application (2012-2017)

Table North America Latanoprost Sales Share by Application (2012-2017)

Figure North America Open-angle Glaucoma Sales Growth (2012-2017)

Figure North America Close-angle Glaucoma Sales Growth (2012-2017)

Figure United States Latanoprost Revenue and Growth (2012-2017)

Figure United States Latanoprost Sales and Growth (2012-2017)

Table United States Latanoprost Sales by Type (2012-2017)

Table United States Latanoprost Sales Market Share by Type (2012-2017)

Table United States Latanoprost Sales by Application (2012-2017)

Table United States Latanoprost Sales Market Share by Application (2012-2017)

Table United States Latanoprost Sales by Manufacturer (2016-2017)

Figure United States Latanoprost Sales Market Share by Manufacturer in 2016

Figure United States Latanoprost Sales Market Share by Manufacturer in 2017

Table United States Latanoprost Revenue by Manufacturer (2016-2017)

Figure United States Latanoprost Revenue Market Share by Manufacturer in 2016

Figure United States Latanoprost Revenue Market Share by Manufacturer in 2017

Table United States Latanoprost Export and Import (2012-2017)

Figure Canada Latanoprost Revenue and Growth (2012-2017)

Figure Canada Latanoprost Sales and Growth (2012-2017)

Table Canada Latanoprost Sales by Type (2012-2017)

Table Canada Latanoprost Sales Market Share by Type (2012-2017)

Table Canada Latanoprost Sales by Application (2012-2017)

Table Canada Latanoprost Sales Market Share by Application (2012-2017)

Table Canada Latanoprost Sales by Manufacturer (2016-2017)

Figure Canada Latanoprost Sales Market Share by Manufacturer in 2016

Figure Canada Latanoprost Sales Market Share by Manufacturer in 2017

Table Canada Latanoprost Revenue by Manufacturer (2016-2017)

Figure Canada Latanoprost Revenue Market Share by Manufacturer in 2016

Figure Canada Latanoprost Revenue Market Share by Manufacturer in 2017

Table Canada Latanoprost Export and Import (2012-2017)

Figure Mexico Latanoprost Revenue and Growth (2012-2017)

Figure Mexico Latanoprost Sales and Growth (2012-2017)

Table Mexico Latanoprost Sales by Type (2012-2017)

Table Mexico Latanoprost Sales Market Share by Type (2012-2017)

Table Mexico Latanoprost Sales by Application (2012-2017)

Table Mexico Latanoprost Sales Market Share by Application (2012-2017)

Table Mexico Latanoprost Sales by Manufacturer (2016-2017)

Figure Mexico Latanoprost Sales Market Share by Manufacturer in 2016

Figure Mexico Latanoprost Sales Market Share by Manufacturer in 2017

Table Mexico Latanoprost Revenue by Manufacturer (2016-2017)

Figure Mexico Latanoprost Revenue Market Share by Manufacturer in 2016

Figure Mexico Latanoprost Revenue Market Share by Manufacturer in 2017

Table Mexico Latanoprost Export and Import (2012-2017)

Figure North America Latanoprost Sales, Revenue and Growth Rate (2017-2022)

Table North America Latanoprost Sales Forecast by Countries (2017-2022)

Table North America Latanoprost Market Share Forecast by Countries (2017-2022)

Figure United States Latanoprost Sales Forecast (2017-2022)

Figure Canada Latanoprost Sales Forecast (2017-2022)

Figure Mexico Latanoprost Sales Forecast (2017-2022)

Table North America Latanoprost Sales Forecast by Type (2017-2022)

Table North America Latanoprost Market Share Forecast by Type (2017-2022)

Table North America Latanoprost Sales Forecast by Application (2017-2022)

Table North America Latanoprost Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Latanoprost

Figure Manufacturing Process Analysis of Latanoprost

Figure Latanoprost Industrial Chain Analysis

Table Raw Materials Sources of Latanoprost Major Manufacturers in 2016

Table Major Buyers of Latanoprost

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370